Orthofix Medical Inc. (OFIX)
OFIX Stock Price Chart
Explore Orthofix Medical Inc. interactive price chart. Choose custom timeframes to analyze OFIX price movements and trends.
OFIX Company Profile
Discover essential business fundamentals and corporate details for Orthofix Medical Inc. (OFIX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
24 Apr 1992
Employees
1.62K
Website
https://www.orthofix.comCEO
Massimo Calafiore
Description
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
OFIX Financial Timeline
Browse a chronological timeline of Orthofix Medical Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is $0.18.
Earnings released on 5 Aug 2025
EPS came in at -$0.36 falling short of the estimated $0.04 by -1.00K%, while revenue for the quarter reached $203.12M , beating expectations by +3.05%.
Earnings released on 6 May 2025
EPS came in at -$0.08 surpassing the estimated -$0.17 by +52.94%, while revenue for the quarter reached $193.65M , missing expectations by -5.19%.
Earnings released on 25 Feb 2025
EPS came in at $0.02 falling short of the estimated $0.06 by -66.67%, while revenue for the quarter reached $215.66M , beating expectations by +7.99%.
Earnings released on 7 Nov 2024
EPS came in at $0.07 surpassing the estimated -$0.14 by +150.00%, while revenue for the quarter reached $196.61M , missing expectations by -7.62%.
Earnings released on 6 Aug 2024
EPS came in at $0.05 surpassing the estimated -$0.13 by +138.46%, while revenue for the quarter reached $198.62M , beating expectations by +1.74%.
Earnings released on 7 May 2024
EPS came in at -$0.46 falling short of the estimated -$0.32 by -43.75%, while revenue for the quarter reached $188.61M , beating expectations by +2.43%.
Earnings released on 5 Mar 2024
EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $200.42M , beating expectations by +2.61%.
Earnings released on 8 Nov 2023
EPS came in at $0.07 surpassing the estimated -$0.22 by +131.82%, while revenue for the quarter reached $184.01M , missing expectations by -5.85%.
Earnings released on 8 Aug 2023
EPS came in at $0.02 surpassing the estimated -$0.67 by +102.99%, while revenue for the quarter reached $187.02M , beating expectations by +0.75%.
Earnings released on 9 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.20 by +50.00%, while revenue for the quarter reached $175.20M , beating expectations by +4.02%.
Earnings released on 6 Mar 2023
EPS came in at $0.19 surpassing the estimated -$0.37 by +151.35%, while revenue for the quarter reached $122.23M , missing expectations by -15.68%.
Earnings released on 3 Nov 2022
EPS came in at $0.13 surpassing the estimated $0.12 by +11.40%, while revenue for the quarter reached $114.00M , missing expectations by 0.00%.
Earnings released on 5 Aug 2022
EPS came in at $0.08 surpassing the estimated $0.07 by +14.29%, while revenue for the quarter reached $118.07M , missing expectations by -0.15%.
Earnings released on 6 May 2022
EPS came in at -$0.10 falling short of the estimated $0.18 by -155.56%, while revenue for the quarter reached $106.42M , beating expectations by +1.98%.
Earnings released on 25 Feb 2022
EPS came in at $0.27 surpassing the estimated $0.13 by +107.69%, while revenue for the quarter reached $125.06M , beating expectations by +0.05%.
Earnings released on 5 Nov 2021
EPS came in at $0.10 falling short of the estimated $0.13 by -23.08%, while revenue for the quarter reached $112.43M , missing expectations by -8.18%.
Earnings released on 6 Aug 2021
EPS came in at $0.32 surpassing the estimated $0.16 by +100.00%, while revenue for the quarter reached $121.39M , beating expectations by +12.19%.
Earnings released on 30 Apr 2021
EPS came in at $0.17 surpassing the estimated $0.07 by +142.86%, while revenue for the quarter reached $105.59M , missing expectations by -82.91%.
Earnings released on 26 Feb 2021
EPS came in at $0.44 surpassing the estimated $0.15 by +193.33%, while revenue for the quarter reached $117.62M , beating expectations by +27.95%.
Earnings released on 5 Nov 2020
EPS came in at $0.31 surpassing the estimated -$0.36 by +186.11%, while revenue for the quarter reached $110.99M , missing expectations by -13.89%.
OFIX Stock Performance
Access detailed OFIX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.